FDA Drug Application (022522) for DALIRESP by ASTRAZENECA PHARMS

Back to FDA Applications sponsored by ASTRAZENECA PHARMS

Application Number022522
Product Number001
FormTABLET;ORAL
Dosage500MCG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDALIRESP
Active IngredientROFLUMILAST



Back to FDA Applications sponsored by ASTRAZENECA PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.